![]() |
市场调查报告书
商品编码
1789946
医药物流市场规模、份额和趋势分析报告:按类型、组成部分、地区和细分市场预测,2025 年至 2033 年Pharmaceutical Logistics Market Size, Share & Trends Analysis Report By Type (Cold Chain Logistics, Non-cold Chain Logistics), By Component (Storage (Warehouse, Refrigerator Containers), Transportation), By Region, And Segment Forecasts, 2025 - 2033 |
医学物流市场概览
2024 年全球医药物流市场价值估计为 993.3 亿美元,预计到 2033 年将达到 2,082.6 亿美元,2025 年至 2033 年的复合年增长率为 8.5%。医药物流市场受到对温度敏感药物和生技药品的需求不断增长、全球医药贸易不断增长以及医疗保健电子商务扩张的推动。
低温运输物流的进步、药品安全监管要求的严格以及追踪技术的日益普及,进一步推动了市场的成长。此外,慢性病的日益普及以及对及时安全配送药品(包括疫苗和特殊药品)的需求,也推动了医药产业对专业物流服务的依赖程度的提高。随着上述疫苗核准使用,主要疫苗製造商正在积极考虑在全球分销这些疫苗。确保全球范围内紧急使用疫苗需要一条韧性十足的供应链,预计这将在预测期内显着推动市场成长。
此外,用于治疗感染疾病(COVID-19) 的药物需求也有望推动市场成长。市场成长也归因于对非处方药 (OTC) 的需求不断增长,例如维生素、矿物质和补充剂 (VMS)、常见的咳嗽和感冒药、胃肠道药物以及皮肤科产品。医疗保健领域对快速援助日益增长的重要性也推动了医药物流市场的发展。此外,透过建立单一分销管道来降低分销成本也进一步推动了医药物流的需求。
许多公司正在进行併购,以扩大其地理覆盖范围和专有知识。他们也致力于降低产品的整体包装成本。生物成分和药品的供应链尤其容易受到运输过程中产品掺假以及不遵守联邦法规、标准和指南的风险的影响。因此,企业正在积极投资远端资讯处理和远端监控等最尖端科技,以提供运输过程中的安全性和便利性,从而推动市场成长。
製药商越来越多地委託标籤和包装业务外包给第三方供应商。许多製药公司正在向拉丁美洲和撒哈拉以南非洲等服务不足的地区扩张。对于製药商而言,选择拥有强大製药专业知识的本地物流供应商至关重要。然而,服务水准低落和失控是外包业务面临的主要威胁。
在美国,由于学名药的改革,对学名药物流的需求不断增长。北美的医药物流市场高度分散,由多家区域性和国际性公司组成。众多区域性和全球性公司的存在使得该行业竞争激烈。
领先的公司正致力于提供云端基础的供应链解决方案和安全的供应链能力。这些解决方案可以防止假药和医疗设备的生产。预计海运和空运医药物流需求的不断增长将在预测期内推动产业成长。海运药品可降低高达 80.0% 的运输成本,并减少所需人员。
此外,这种先进的包装有助于优化包装和储存要求,同时最大限度地减少物流业务的碳排放。高价值药品和疫苗的远距和洲际运输对航空货运物流的依赖日益增加,预计也将进一步推动市场成长。
Pharmaceutical Logistics Market Summary
The global pharmaceutical logistics market size was estimated at USD 99.33 billion in 2024 and is projected to reach USD 208.26 billion in 2033, growing at a CAGR of 8.5% from 2025 to 2033. The pharmaceutical logistics market is driven by the growing demand for temperature-sensitive drugs and biologics, rising global pharmaceutical trade, and the expansion of e-commerce in healthcare.
Advancements in cold chain logistics, stringent regulatory requirements for drug safety, and increasing adoption of track-and-trace technologies further propel market growth. Additionally, the rising prevalence of chronic diseases and the need for timely and secure delivery of medications, including vaccines and specialty drugs, are contributing to the increased reliance on specialized logistics services in the pharmaceutical sector. With the approval of the aforementioned vaccines for usage, key vaccine producers are actively looking to distribute these vaccines around the globe. It would need a resilient supply chain to make vaccines available across the globe for urgent usage. Therefore, it is estimated to drive the growth of the market at a significant pace during the forecast period.
Along with this, the demand for medicines used for curing the novel coronavirus disease is also expected to boost the market growth. The growth of the market is also attributed to the increasing demand for Over-the-Counter (OTC) medicines such as Vitamins, Minerals, and Supplements (VMS), common cough and cold drugs, gastrointestinal drugs, and dermatology products. The rising importance of fast-track assistance in the healthcare sector is also driving the market for pharmaceutical logistics. Moreover, decreasing the distribution cost by creating a single source distribution channel further increases the demand for pharmaceutical logistics.
Many companies are entering into mergers and acquisitions to expand their geographical presence and proprietary knowledge. They are also focusing on reducing the overall packaging costs of their products. The biocomponent and pharmaceutical supply chains are particularly prone to the risks associated with product adulteration during transport as well as non-compliance with federal regulations, standards, and guidelines. As a result, the players are actively investing in state-of-the-art technologies such as telematics and remote monitoring to provide safety and convenience during transportation operations, which is, in turn, propelling the market growth.
Pharmaceutical manufacturing companies are increasingly outsourcing labeling and packaging activities to third-party providers. Many pharmaceutical companies are expanding their operations in untapped regions, including Latin America and Sub-Saharan Africa. The preference for local logistics providers with high expertise in pharmaceuticals is of great importance to drug manufacturers. However, deteriorating service levels and loss of control are significant threats that are faced in outsourcing operations.
The demand for pharmaceutical logistics is growing in the U.S. due to increasing sales of generic drugs, as well as reforms in the healthcare sector favoring generics. The market for pharmaceutical logistics in North America is significantly fragmented, owing to several regional and international companies. The industry is highly competitive due to the presence of many local and global companies.
Major companies strive to offer cloud-based supply chain solutions and secure supply chain functions, as it helps manufacturers ensure the authenticity of the drugs. These solutions prevent the production of counterfeit drugs and medical devices. The increasing demand for sea and air freight pharmaceutical logistics is anticipated to propel industry growth during the forecast period. The transportation of pharma products by sea reduces the transportation cost by up to 80.0% and decreases the staffing requirements.
In addition, these advancements help optimize packaging and storage requirements while minimizing the carbon footprint of logistics operations. The growing reliance on air freight logistics for the long-distance and intercontinental transport of high-value medicines and vaccines is also anticipated to further drive market growth.
Global Pharmaceutical Logistics Market Report Segmentation
The report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical logistics market report based on type, component, and region: